SCHEMBL369315

SCHEMBL369315

COC(=O)[C@H](CCP(=O)(O)Cc1cc(OC)c(O)c([N+](=O)[O-])c1)NC(=O)OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 6/20 0.61
GRM8 O00222 5/20 0.61
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
MCL1 Q07820 1/20 0.48
GSTP1 P09211 1/20 0.45
GSTM2 P28161 1/20 0.45
KYNU Q16719 1/20 0.44
GRM6 O15303 3/20 0.42
GRM7 Q14831 2/20 0.42
CTSL P07711 3/20 0.40
CTSB P07858 3/20 0.40
ABCB1 P08183 1/20 0.39
ABCC1 P33527 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL371150 0.87 GRM4 (0.56) GRM4GRM8MEN1KMT2AALDH1A1
SCHEMBL10000467 0.85 GRM8 (0.61) GRM4GRM8MEN1KMT2AALDH1A1
SCHEMBL346474 0.85 GRM8 (0.51) GRM4GRM8MEN1KMT2AALDH1A1
SCHEMBL346473 0.85 GRM8 (0.51) GRM4GRM8MEN1KMT2AALDH1A1
SCHEMBL345272 0.83 GRM8 (0.58) GRM4GRM8ALDH1A1GSTP1GSTM2
SCHEMBL345271 0.83 GRM8 (0.58) GRM4GRM8ALDH1A1GSTP1GSTM2
SCHEMBL346475 0.82 MEN1 (0.46) GRM4GRM8MEN1KMT2AALDH1A1
SCHEMBL13858807 0.81 GSTP1 (0.43) GRM4GRM8MEN1KMT2AALDH1A1
SCHEMBL13858941 0.79 GSTP1 (0.50) GRM4GRM8ALDH1A1POLBMAPT
SCHEMBL10000468 0.79 GRM8 (0.61) GRM4GRM8MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120016155-A1 DIASTEREOISOMERS OF HYPOPHOSPHOROUS ACID DERIVATIVES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-01-19 US disclosed
US-20120016155-A1 DIASTEREOISOMERS OF HYPOPHOSPHOROUS ACID DERIVATIVES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-01-19 US disclosed
US-20120016155-A1 DIASTEREOISOMERS OF HYPOPHOSPHOROUS ACID DERIVATIVES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-01-19 US disclosed
WO-2010106526-A1 DIASTEREOISOMERS OF HYPOPHOSPHOROUS ACID DERIVATIVES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016155-A1 DIASTEREOISOMERS OF HYPOPHOSPHOROUS ACID DERIVATIVES PTH1R, P4HA1, FGF23 GRM4 3644/4885GRM8 4160/4885MEN1 1060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.